Autoimmune Hemolytic Anemia
Autoimmune hemolytic anemia (AIHA) is a condition where the immune system mistakenly attacks and destroys red blood cells, leading to anemia. This can result in symptoms such as fatigue, weakness, and pale skin.
Warm Autoimmune Hemolytic Anemia: Rilzabrutinib Study
We are investigating whether the oral medication rilzabrutinib can improve hemoglobin levels and reduce symptoms in adults with warm autoimmune hemolytic anemia. This study will also assess its safety compared to a placebo.
1-2 yearsConfirmation phase (III)Post-Trial Drug AccessInvestigational MedicinesOralHematologyInternal Medicine
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you between 18 and 75 years old?
- Do you have a confirmed diagnosis of primary wAIHA (warm autoimmune hemolytic anemia) for at least 3 months?
- Have you had any major health issues like cancer, HIV, or active hepatitis B or C?
- Are you currently taking any experimental drugs or have you taken BTK inhibitors for wAIHA before this study?
- Have you had any serious allergic reactions to medications that would prevent you from participating in this study?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Rilzabrutinib
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Hanusch Krankenhaus Der Wiener Gebietskrankenkasse
Hanusch Hospital, 3rd Medical Department
Vienna, Austria
Medical University Of Vienna
Allgemeines Krankenhaus Medizinische Universität Wien, Clinical Pharmacology
Vienna, Austria
Fakultni Nemocnice Brno
Interni hematologicka a onkologicka klinika
Brno, Czechia
Sponsor: Sanofi-Aventis Recherche & Developpement
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.